Amundi Asset Management US’s Ionis Pharmaceuticals IONS Stock Holding History

Amundi Asset Management US’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$3.69M	Buy	82,126 +17,669	+27%	+$985K	﹤0.01%	1087
2020 Q4	$3.64M	Buy	64,457 +16,372	+34%	+$816K	﹤0.01%	1042
2020 Q3	$2.28M	Buy	48,085 +13,682	+40%	+$760K	﹤0.01%	1074
2020 Q2	$2.03M	Buy	34,403 +7,338	+27%	+$408K	﹤0.01%	1072
2020 Q1	$1.28M	Sell	27,065 -8,624	-24%	-$481K	﹤0.01%	1048
2019 Q4	$2.16M	Hold	35,689	–	–	﹤0.01%	1103
2019 Q3	$2.14M	Buy	35,689 +5,065	+17%	+$330K	﹤0.01%	1081
2019 Q2	$1.97M	Buy	+30,624	New	+$2.16M	﹤0.01%	1142

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Amundi Asset Management US's IONS Position: Q1 2021 in Review

Amundi Asset Management US increased its Ionis Pharmaceuticals (IONS) stake by 27% in Q1 2021, buying an estimated $985K and bringing the position to 82,126 shares worth $3.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1087.

Amundi Asset Management US first reported a position in IONS in Q2 2019 and has held it in 8 quarters since. 365 funds tracked by Wall St. Rank hold IONS as of Q1 2021.

Amundi Asset Management US held 82,126 shares of Ionis Pharmaceuticals worth $3.69M as of Q1 2021.
Amundi Asset Management US bought 17,669 Ionis Pharmaceuticals shares in Q1 2021, an estimated $985K.
Ionis Pharmaceuticals made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1087 holding.
Amundi Asset Management US first reported a position in Ionis Pharmaceuticals in Q2 2019 and has held it in 8 quarters since.
365 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.